Neural Correlates of Repeated tDCS
Investigating the Neural Correlates of Repeated tDCS in MCI and Healthy Ageing With fMRI
1 other identifier
interventional
80
1 country
1
Brief Summary
Healthy ageing and pathological ageing in the context of a neurodegenerative disease are both associated with changes in brain network integrity. Episodic memory is especially affected in Alzheimer's disease, but is also decreased in healthy ageing. Consequently, the memory-relevant brain networks are especially altered. Transcranial direct current stimulation (tDCS) has previously been implemented in different clinical- and non-clinical settings and has shown to beneficially influence network connectivity. The neural correlates of single-session tDCS have been investigated, however, the neural effects of repeated tDCS remain unknown. Furthermore, knowledge about the (long-term) neural mechanisms of repeated tDCS can give valuable insights and possibly pave the ground for exploring tDCS as a treatment option in future studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 23, 2016
CompletedFirst Posted
Study publicly available on registry
December 19, 2016
CompletedStudy Start
First participant enrolled
May 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedMarch 26, 2018
March 1, 2018
1.6 years
November 23, 2016
March 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
neural changes after multi-session tDCS
fMRI-BOLD response
5-12 days
network changes after multi-session tDCS
functional connectivity between network hubs
5-12 days
Secondary Outcomes (1)
Task performance changes after multi-session tDCS
5-12 days
Study Arms (4)
MCI-active
EXPERIMENTALPatients will receive verum tDCS over the angular gyrus on five consecutive days.
MCI-sham
SHAM COMPARATORPatients will receive sham tDCS over the angular gyrus on five consecutive days.
Healthy Old-active
EXPERIMENTALParticipants will receive verum tDCS over the angular gyrus on five consecutive days.
Healthy old-sham
SHAM COMPARATORParticipants will receive sham tDCS over the angular gyrus on five consecutive days.
Interventions
Participants will receive active tDCS over the angular gyrus on five consecutive days
Participants will receive sham tDCS over the angular gyrus on five consecutive days
Eligibility Criteria
You may qualify if:
- Patients
- Diagnosis of MCI based on the latest research criteria (clinical assessment at the memory clinic (prof. Frans RJ Verhey): presence of at least a memory impairment, memory complaints expressed by the patient or informant, no problems in daily life functioning, no dementia and presence of biomarkers (Albert et al., 2011)
- Clinical Dementia Rating score of 0.5 (CDR distinguishes a stage of questionable dementia (CDR 0.5) from people termed healthy (CDR 0) and those with mild dementia (CDR 1)
- Mini-Mental State Examination (MMSE) 23 and being mentally competent (in general, individuals with a MMSE 18 are considered mentally competent)
- Age: between 60 and 85 years old
- % female
- Right-handedness
- Average level of education (CBS level 3-4-5-6)
- Healthy controls
- Average neuropsychological test results, in accordance with normative data, corrected for age, education and gender
- No substantial memory complaints (according to the participant)
- Age: between 60 and 85 years old
- % female
- Right-handedness
- Average level of education (CBS level 3-4-5-6)
- +1 more criteria
You may not qualify if:
- Psychoactive medication use
- Abuse of alcohol and drugs
- Cognitive impairment due to alcohol/drug abuse or abuse of other substances
- Past or present psychiatric or neurological disorders (major depression, schizophrenia, bipolar disorder, psychotic disorder (or treatment for it), epilepsy, stroke, Parkinson's disease, multiple sclerosis, brain surgery, brain trauma, electroshock therapy, kidney dialysis, Menière's disease, brain infections)
- Major vascular disorders (e.g. stroke)
- Heart diseases or pacemakers
- Contraindications for scanning (e.g. brain surgery, cardiac pacemaker, metal implants, claustrophobia, body tattoos)
- Large scars or fresh wounds on the scalp
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University
Maastricht, Limburg, 6221ET, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heidi IL Jacobs, PhD
Maastricht University
- STUDY CHAIR
Frans RJ Verhey, Professor
Maastricht University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2016
First Posted
December 19, 2016
Study Start
May 2, 2017
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
March 26, 2018
Record last verified: 2018-03